About us
Indivior is a global pharmaceutical company working to help change patients' lives by developing medicines to treat opioid use disorder (OUD). Our vision is that all patients around the world will have access to evidence-based treatment for OUD and we are dedicated to transforming OUD from a global human crisis to a recognized and treated chronic disease. Building on its global portfolio of OUD treatments, Indivior has a pipeline of product candidates designed to expand on its heritage in this category. Headquartered in the United States in Richmond, VA, Indivior employs more than 1,000 individuals globally and its portfolio of products is available in over 30 countries worldwide. Our guiding principles foster a corporate culture of trust, innovation, and a pioneering spirit: • Focus on patient needs to drive decisions • Seek the wisdom of the team • Believe that people’s actions are well intended • Care enough to coach • See it, own it, make it happen • Demonstrate honesty and integrity at all times Community guidelines: https://bit.ly/43QuKrw
- Website
-
http://www.indivior.com
External link for Indivior
- Industry
- Pharmaceutical Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Richmond, VA
- Type
- Public Company
- Specialties
- Opioid use disorder and Rescue Medications
Locations
-
Primary
Get directions
.
Richmond, VA, US
-
Get directions
.
Slough, GB
-
Get directions
.
Hull, GB
-
Get directions
.
Ft. Collins, CO, US
Employees at Indivior
-
Nicolas Fouché
Senior Vice-President, Head of Europe, Canada and Middle - East
-
Mark Stejbach
Biotech board member and consultant
-
Pauline Whelan
Government Affairs Executive for Specialty Pharma ➜ Strategic Planning + Strategy Execution that Secures State Funding | Lobbying Yielding…
-
Johan V.
Indivior
Updates
-
During Substance Use Prevention Month we recognize that substance use disorder (SUD) can affect any of us. Your sibling, child, parent, friend, coworker or others could be struggling with SUD and searching for help. Nearly 1 in 6 Americans aged 12 and older, about 48.4 million people, had a substance use disorder (SUD) in the past year. According to the CDC, early intervention through strategies like family-based programs, school initiatives, and healthcare screenings can delay the onset of substance use and reduce the risk of long-term health issues, including addiction and overdose. At Indivior we want to thank the people and community leaders working every day to promote prevention and early intervention strategies so that more people suffering from SUD have access to care. Together, we can create a brighter future for people experiencing SUD. To learn more about prevention resources and events, visit: https://lnkd.in/g7C66-Dh
-
-
New findings from a multicenter clinical trial evaluating rapid induction with extended-release buprenorphine for opioid use disorder have been published in JAMA Network Open. Learn more in our press release here: https://lnkd.in/dV4Mh6tJ
-
Attending the American Psychiatric Nurses Association (APNA) annual conference in New Orleans, LA? Visit the Indivior Medical Affairs team at Booth 123 to learn more about treatment for opioid use disorder. #OUD #OverdoseReversal
-
-
On International Recovery Day, we honor the 1.2 million Americans in recovery from opioid use disorder and the communities that helped them get there. This global observance unites recovery communities across six continents and dozens of countries, celebrating all pathways to healing, from peer support to clinical care. Recovery is possible, but it’s not guaranteed. In 2024, an estimated 3 million people in the U.S. met the criteria for opioid use disorder, and many still face barriers to care. We’ve made progress, but there’s more to do to ensure recovery is accessible to everyone. To learn more, visit: https://lnkd.in/drwjF6R
-
-
Attending the American Academy of Family Physicians FMX conference #AAFPFMX in Anaheim, CA? Visit the Indivior North America Medical Affairs team at Booth 455 to learn more about treatments for opioid use disorder #OUD and #OverdoseReversal.
-
-
Indivior reposted this
Last week, the Senate passed the SUPPORT for Patients and Communities Reauthorization Act, marking an important step forward in addressing the opioid crisis. We appreciate the continued bipartisan commitment to expanding access to prevention, treatment, and recovery services for those impacted by opioid use disorder. #SUPPORTAct #OUDRecovery